Consultant
MHC Therapeutics Bioconsulting
Minneapolis, MN
Abeer Madbouly, PhD is the Principal and Founder of MHC Therapeutics Bioconsulting (MTB), where she provides expertise in immunogenetics, HLA/KIR data analysis, imputation, and population genetics to support stem-cell transplantation, solid organ transplantation, and emerging cell and gene therapies. She previously spent 15 years at the NMDP as a Principal Bioinformatics Scientist and Cell & Gene Therapies Lead, contributing to donor–recipient matching methods, validation pipelines, and ancestry-informed analyses. Author of 70+ publications, Dr. Madbouly also serves as Associate Editor for Human Immunology, Frontiers in Genetics, and Frontiers in Immunology, holds an adjunct faculty appointment at the University of Minnesota, and has held leadership roles in ASHI and the NMDP Diversity, Equity, and Inclusion Council.
Featured Topic: From Code to Care: AI’s Promise & Pitfalls in Medicine
Monday, October 6, 2025
12:30 PM - 5:00 PM US EDT
Monday, October 6, 2025
1:55 PM - 3:40 PM US EDT
Tuesday, October 7, 2025
10:00 AM - 10:15 AM US EDT
Tuesday, October 7, 2025
10:15 AM - 10:30 AM US EDT
Tuesday, October 7, 2025
2:45 PM - 4:15 PM US EDT
Thursday, October 9, 2025
6:45 AM - 7:45 AM US EDT
Thursday, October 9, 2025
10:00 AM - 10:15 AM US EDT
Thursday, October 9, 2025
10:15 AM - 10:30 AM US EDT